Speaker Profile

Ph.D., CTO, Genomill Health Inc

Biography
Manu Tamminen is an expert in molecular biology, next- generation DNA sequencing and bioinformatics. He received his PhD from the University of Helsinki and did his post-doctoral research at MIT and ETH Zürich, where he developed methodologies for single cell sequencing and molecular counting. He is currently an Adjunct Professor and Academy Fellow at the University of Turku and has authored several high-impact research publications.


Clinical Dx Showcase:
Genomill Health

Genomill Health is a pioneering precision diagnostics company with a mission to make molecular diagnostics more scalable, sensitive and accessible for all.

Geno1 - Scalable, Sensitive and Cost-efficient Liquid Biopsies
Geno1 is a pre-sequencing platform enabling improvements in performance, cost and scalability for liquid biopsies and beyond. Geno1 combines proprietary probe design with patented NGS library preparation and AI-powered sequence processing. We present analytical validation and clinical verification of Geno1.

 Session Abstract – PMWC 2022 Silicon Valley

Track 6, June 28-30


The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative